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Abstract Using site-directed tryptophan fluorescence we stud-
ied nucleotide occupancy of the catalytic sites of Escherichia coli 
Fi-ATPase, under conditions used previously for crystallization 
and X-ray structure analysis of the bovine mitochondrial enzyme 
[Abrahams et al. (1994) Nature 370, 621-628). We found that 
only two of the three catalytic sites were filled in the E. coli 
enzyme under these conditions (250 uM MgAMPPNP plus 5 uM 
MgADP), consistent with what was reported in the bovine Fx X-
ray structure. However, subsequent addition of a physiological 
concentration of MgATP readily filled the third catalytic site. 
Therefore the enzyme form seen in the X-ray structure results 
from the fact that it is obtained under sub-saturating nucleotide 
conditions. The data show that the X-ray structure is compatible 
with a catalytic mechanism in which all three Fi-ATPase 
catalytic sites must fill with MgATP to initiate steady-state 
hydrolysis |e.g. Weber and Senior (1996) Biochim. Biophys. Acta 
1275, 101-104]. The data further demonstrate that the site-
directed tryptophan fluorescence technique can provide valuable 
support for F] crystallography studies. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
ATP synthase is the membrane enzyme responsible for ATP 
synthesis in mitochondria and chloroplasts. In bacteria it per-
forms both ATP synthesis and ATP-driven proton transport. 
The Fi catalytic sector may be purified in soluble form as an 
active ATPase [1-5]. Since 1981 the model of Cross [6] has 
provided a working hypothesis for the enzyme mechanism. 
Briefly it proposes that the three catalytic sites of Fi have 
widely different affinities for substrate. Under substrate satu-
ration conditions, one of the three sites is always empty, and 
immediately after the product release step, two sites are 
empty. A structure of bovine heart mitochondrial Fi deter-
mined by X-ray crystallography [7] showed two catalytic sites 
occupied by nucleotide and one site empty. This was inter-
preted as consistent with the Cross model [7]. 
Direct equilibrium measurement of nucleotide binding pa-
rameters for the three catalytic sites of Fi became possible 
only recently, when we introduced the technique of site-di-
rected tryptophan fluorescence to provide specific optical 
probes [8]. We demonstrated that substrate MgATP, at phys-
iological, saturating (Kmax) concentration (>1 mM), binds to 
all three catalytic sites, and that the sites do indeed show 
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widely different binding affinity (Kdl, 1(T
10 M; Kd2, 1(T
6 M; 
Kd3, 10"
4 M) [9,10]. We further demonstrated that all three 
catalytic sites must bind MgATP for physiological activity to 
be achieved, and that molecules with only two sites filled show 
negligible activity [9]. Under steady-state MgATP hydrolysis 
conditions, one site is occupied by MgATP and two by 
MgADP [11]. Independent corroboration of the site-directed 
tryptophan fluorescence technique came from 2-azido-ATP 
photolabelling experiments [12]. 
These new data point strongly to a model for the catalytic 
mechanism of Fi-ATPase in which all three catalytic sites are 
filled at saturating substrate concentration, and immediately 
after product release only one catalytic site is empty, as pro-
posed in [8]. This model therefore supersedes the Cross model, 
while incorporating several of its important features. 
The X-ray structure [7] is not incompatible with the new 
model, because the Fi form seen in the crystals could well 
correspond to the species that occurs immediately after prod-
uct release during steady-state turnover. However, we felt it 
important to examine why Fi in the crystals has only two 
catalytic sites occupied. One plausible explanation was that, 
under the conditions of crystallization, the concentrations of 
nucleotide (250 uM MgAMPPNP, 5 uM MgADP) are insuf-
ficient to fill the third catalytic site. Using Escherichia coli Fi, 
we measured nucleotide occupancy of catalytic sites under the 
crystallization conditions, and we tested what happened when 
saturating concentrations of MgATP were subsequently 
added. 
2. Materials and methods 
2.1. Enzyme preparations 
E. coli Fi was purified as described [13]. Wild-type Fi was from 
strain SWM1 [14], [3Y331W Fi from strain SWM4 [9], (3F148W Fi 
from strain CB1 [11], and aR365W Fi from strain AW7 [15]. Prep-
aration of nucleotide-depleted Fi was as in [16]. Before use nucleo-
tide-depleted enzyme was passed once through a 1 ml centrifuge col-
umn of Sephadex G-50 [17] equilibrated in 50 mM Tris-S04, pH 8.0. 
'Native' Fi was enzyme that was passed twice through centrifuge 
columns as above. Previous work has established that this procedure 
effectively removes catalytic but not noncatalytic site-bound nucleo-
tide [10,18]. 
2.2. Nucleotide binding assays by fluorescence measurement 
Fluorescence measurements were made at 22°C and enzyme con-
centration of 100 nM, in 2 ml buffer consisting of 50 mM Tris-HCl, 
pH 8.2, 1 mM EDTA, 200 mM NaCl, 5 mM 2-mercaptoethanol, 
5 mM dithiothreitol, 20 mM MgS04, 3 mM NaN3, 0.001% (w/v) 
phenylmethylsulfonyl fluoride, with other additions or subtractions 
as indicated in the text. Excitation was at 295 nm, fluorescence was 
monitored in a SPEX Fluorolog 2 Spectro-fluorimeter equipped with 
DataMax Software. Background signals (buffer, Raman scatter) were 
subtracted; inner filter and volume effects were corrected for by con-
trol experiments with wild-type enzyme. Wild-type enzyme showed no 
significant fluorescence changes on addition of nucleotides. 
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3. Results and discussion 
PY331W mutant E. coli Fi, which shows normal function 
[9], contains a Tyr->Trp substitution in each of the three 
catalytic sites. In wild-type, Tyr-331 makes Van der Waals 
contact with the adenine ring of bound nucleotide [7]. On 
binding of nucleotide to PY331W enzyme, the large fluores-
cence signal of the three Trp-331 residues is virtually fully 
quenched [9,10]. Fig. 1 shows fluorescence spectra of 
PY331W and wild-type Fi obtained in buffer which mimics 
the crystallization buffer used by Walker and colleagues for 
X-ray crystallography [19]. The fluorescence of both enzymes 
was reduced by about 50% as compared to previous measure-
ments made in 50 mM Tris-S04, pH 8.0, buffer [9,10], but the 
signals were nevertheless easily sufficient for nucleotide bind-
ing measurements. Curve a in Fig. 1 represents the spectrum 
of nucleotide-depleted PY331W enzyme alone. On addition of 
250 uM AMPPNP simultaneously with 5 uM ADP, the fluo-
rescence was partly quenched (curve b). The degree of quench-
ing of fluorescence at X = 360 nm indicates an average occu-
pation of two catalytic sites per enzyme molecule. On addition 
of 5 mM ATP, further quenching occurred (curve c) close to 
the level of fluorescence seen in wild-type (curve d), indicating 
that all three catalytic sites were now occupied. Multiple rep-
licate experiments of this kind were carried out, with highly 
consistent results, and the data are summarized in Table 1. 
The conclusion is that under these conditions, either 250 u\M 
AMPPNP alone, or the combination of 250 uM AMPPNP 
with 5 uM ADP, are not sufficient to fill the third catalytic 
site, but subsequent addition of physiological concentration of 
ATP readily does so, and the resultant enzyme has all three 
sites filled. It should be noted that since the buffer contains 20 
mM MgS04, each nucleotide is present as Mg-complex. 
The conditions used in the above experiments were intended 
to mimic as closely as possible those used by Lutter et al. [19] 
for crystallization of bovine heart mitochondrial Fi. It is im-
portant to discuss how well this goal was met. The major 
Table 1 
Nucleotide occupancy of catalytic sites of PY331W mutant E. coli 
Fi under conditions mimicking those used for crystallization of beef 
heart mitochondrial Fi 
Nucleotide occupancy of catalytic sites 
Nucleotide-
depleted Fi 
Native Fi 
+ NaN, NaN* + NaN3 NaN, 
AMPPNP 1.9 1.9 1.8 1.95 
AMPPNP then ATP 2.9 2.8 2.75 2.8 
AMPPNP/ADP 2.05 1.9 1.95 2.05 
AMPPNP/ADP then ATP 2.8 2.75 2.8 2.8 
ATP alone 2.8 - 2.8 2.9 
Catalytic site nucleotide occupancy was determined by fluorescence 
spectroscopy as described in Section 2 and is presented as mol/mol 
Fi. The enzyme concentration was 100 nM, and NaN3 was 3 mM 
when present. Additions are described in column 1. 'AMPPNP' in-
dicates addition of AMPPNP alone (final concentration = 250 uM); 
'AMPPNP/ADP' indicates addition of 250 uM AMPPNP and 5 uM 
ADP (final concentrations) simultaneously; 'then ATP' indicates the 
subsequent addition of 5 mM ATP after either AMPPNP or 
AMPPNP/ADP; 'ATP alone' indicates addition of 5 mM ATP with-
out AMPPNP or ADP. The buffer contained 20 mM MgS04, hence 
all nucleotides are present as Mg-complexes. Data shown are means 
of 3 or 4 experiments which showed excellent agreement in every case. 
320 340 360 380 
wavelength (nm) 
Fig. 1. Fluorescence spectra of pY331W mutant E. coli Fi in 'crys-
tallization buffer'. Fluorescence emission spectra (A x^c = 295 nm) 
were obtained as described in Section 2. Curve a, (3Y331W mutant 
Fi; curve b, (3Y331W ¥x with 250 uM AMPPNP plus 5 uM ADP; 
curve c, subsequent addition of 5 mM ATP; curve d, wild-type 
E. coli Fi, with or without the same nucleotide additions. 
difference between our experiments and those of Lutter et 
al. is that we used E. coli Fi and they used bovine heart 
mitochondrial Fi, so the question arises as to whether the 
former provides a valid experimental model for the latter. 
As to binding of MgAMPPNP and/or MgADP at the first, 
highest affinity catalytic site, it is clear from data in the liter-
ature [9,20-23] that in both enzymes the first catalytic site 
would be expected to be completely filled under the conditions 
used, and obviously this was the case. There is currently no 
equilibrium technique available for specifically determining 
nucleotide binding parameters of the second and third cata-
lytic sites in bovine mitochondrial Fi, this can as yet only be 
done in E. coli enzyme. However, there are strong indications 
that the two enzymes are very similar. First, ^Tm(MgATP) for 
ATPase activity at P"max rate in bovine heart mitochondrial 
Fi, as reported from numerous laboratories, is 100-250 \iM 
[24-29]. For wild-type E. coli enzyme, the same value was 
reported, also from several laboratories [9,30,31], in both e-
depleted and e-replete enzyme [32]. Arcat/A^m(MgATP) for bo-
vine mitochondrial Fi is close to 2X106 M _ 1 s^1 in all the 
reports cited above, and the value for E. coli Fi is the same. 
These two parameters reflect the affinity and rate of MgATP 
binding at the loosest catalytic site, and it is clear that both 
enzymes behave very similarly. PY331W mutant E. coli en-
zyme has A^m(MgATP) lower by 2-fold than wild-type, while 
retaining the same A;cat/Xm(MgATP) [9]. Second, the structure 
of the catalytic sites in the two enzymes appears to be very 
similar indeed. The sequences of the p-subunits are strongly 
conserved, especially in the nucleotide binding domain, and all 
the residues identified at the catalytic sites in the X-ray struc-
ture of the bovine mitochondrial enzyme are present in E. coli 
enzyme [1-5,7]. Certainly the results obtained here substanti-
ate the approach - under the same conditions the same frac-
tional nucleotide occupancy was found. 
We investigated other factors that might have affected nu-
cleotide binding to catalytic sites under the crystallization 
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conditions. As Table 1 shows, sodium azide could be omitted 
without any effect. Lutter et al. [19] used D20-containing 
buffers, which stabilize subunit interactions in bovine heart 
mitochondrial Fi at low or high temperature [33]. We did 
not think this necessary, since it was shown that at 20°C as 
used here, D2O had no effect on Fmax(ATPase) or 
^m(MgATP) [33]. Polyethylene glycol 6000 was used to en-
courage crystal formation [19]. We found that, at 7% (w/v) 
concentration, it caused large and rapid decrease in enzyme 
fluorescence signal, and could not therefore be included in the 
buffer. 
Nucleotide-depleted and 'native' PY331W enzymes behaved 
very similarly (Table 1), showing that the initial state of oc-
cupation of the noncatalytic sites, or the ligands occupying the 
noncatalytic sites, had no effect. We examined the occupancy 
of the three noncatalytic sites under the 'crystallization buffer' 
conditions using ocR365W mutant E. coli Fi. In this enzyme 
the fluorescence of the aW365 residues is virtually completely 
quenched upon binding of nucleotide to noncatalytic nucleo-
tide sites [15]. Nucleotide-depleted ocR365W Fi was incubated 
under the conditions of Table 1, and it was seen that upon 
addition of 250 uM AMPPNP alone, or 250 |iM AMPPNP 
simultaneously with 5 uM ADP, the aW365 fluorescence was 
maximally quenched, and subsequent addition of 5 mM ATP 
had no further effect. Therefore under the 'crystallization' 
conditions all three noncatalytic sites were occupied by nu-
cleotide, consistent with the fact that bovine heart mitochon-
drial Fi in the X-ray structure has all three noncatalytic sites 
occupied by AMPPNP [7]. 
The crystallization buffer contains a high (20 mM) concen-
tration of Mg2+ ion. In separate experiments with (3Y331W 
mutant E. coli Fj we have studied MgATP binding to cata-
lytic sites at concentrations of 2.5, 20 and 25 mM MgS04 . 
With MgATP, we found maximal binding stoichiometries of 
3.0, 2.8 and 2.8 mol/mol Fi, respectively. Thus high Mg2+ 
concentrations caused a slight reduction in apparent stoichi-
ometry of ATP binding to catalytic sites. High Mg2+ concen-
trations are also inhibitory to hydrolysis [22]. Lower concen-
trations may favor full occupancy of sites in future 
crystallization trials. 
It was demonstrated previously that the fluorescence signal 
of pF148W mutant E. coli Fi allows one to discriminate be-
tween nucleoside di- and tri-phosphate bound in catalytic sites 
[11]. Unfortunately we found here that, under the 'crystalliza-
tion buffer' conditions, the fluorescence signal of (3F148W 
enzyme was reduced, such that useful results could not be 
obtained. Instead we performed experiments in 50 mM Tris-
SO4, pH 8.0, 2.5 mM MgSC>4 buffer as reported previously in 
[11]. We compared the spectra obtained on addition of 250 
itM AMPPNP alone versus addition of 250 uM AMPPNP 
plus 5 u,M ADP. The total catalytic site nucleotide binding 
stoichiometry was the same in both cases, but in the former all 
the bound nucleotide was in the form of nucleoside triphos-
phate, as expected, whereas in the latter the ratio of bound 
AMPPNP/bound ADP was 2/1. Thus up to 67% of the mol-
ecules would be in the form seen in the crystal structure, i.e. 
with one bound AMPPNP, one bound ADP, and one empty 
catalytic site. 
Our conclusions are as follows, (i) The reason that Fi mol-
ecules in the X-ray structure of Abrahams et al. [7] have only 
two out of three catalytic sites occupied is that the nucleotide 
concentrations in the crystallization buffer are insufficient to 
saturate the third site. Further addition of MgATP at phys-
iological concentration under these conditions readily satu-
rates the third site. The open structure of the empty catalytic 
site seen in the 'PE ' subunit in [7] is the native, unoccupied 
form; it clearly undergoes profound conformational change 
when it binds and closes around a nucleotide molecule. 
(ii) The work provides support for a 'three-site' mechanism 
of Fi catalysis (e.g. as in [8]), by showing that the X-ray 
structure is compatible with such a mechanism. The Fi species 
seen in the X-ray structure may well correspond to the form 
of the enzyme that occurs immediately after release of product 
from one of the three catalytic sites in the catalytic cycle 
during steady-state turnover (state D of [8]). Interestingly, 
recent work on the X-ray structure of the efrapeptin-F! com-
plex [34] suggests that efrapeptin inhibits Fi by specifically 
binding to the enzyme at this step of the catalytic cycle, 
when one catalytic site is empty, and preventing the third 
site from filling with nucleotide. (iii) Quantitative estimation 
of nucleotide binding parameters obtained from site-directed 
tryptophan fluorescence experiments can be used in future 
work to predict crystallization conditions favoring enzyme 
molecules with specific stoichiometry of bound nucleotide; 
conversely, conditions found by trial and error to favor crys-
tal formation can be readily checked to determine the nucleo-
tide content of the Fi species present. 
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